Deschenes N, Cheng C, Ryckman A, Quinville B, Khanal P, Mitchell M
Int J Mol Sci. 2023; 24(11).
PMID: 37298170
PMC: 10253223.
DOI: 10.3390/ijms24119217.
Benzie G, Bouma K, Battellino T, Cooper S, Hemming R, Kammouni W
BBA Adv. 2023; 2:100032.
PMID: 37082581
PMC: 10074939.
DOI: 10.1016/j.bbadva.2021.100032.
Tropak M, Yonekawa S, Karumuthil-Melethil S, Thompson P, Wakarchuk W, Gray S
Mol Ther Methods Clin Dev. 2016; 3:15057.
PMID: 26966698
PMC: 4774620.
DOI: 10.1038/mtm.2015.57.
Rigat B, Tropak M, Buttner J, Crushell E, Benedict D, Callahan J
Mol Genet Metab. 2012; 107(1-2):203-12.
PMID: 22784478
PMC: 4010500.
DOI: 10.1016/j.ymgme.2012.06.007.
Goddard-Borger E, Tropak M, Yonekawa S, Tysoe C, Mahuran D, Withers S
J Med Chem. 2012; 55(6):2737-45.
PMID: 22360565
PMC: 3380069.
DOI: 10.1021/jm201633y.
2-Acetamino-1,2-dideoxynojirimycin-lysine hybrids as hexosaminidase inhibitors.
Steiner A, Schitter G, Stutz A, Wrodnigg T, Tarling C, Withers S
Tetrahedron Asymmetry. 2012; 20(6-8):832-835.
PMID: 22328804
PMC: 3276585.
DOI: 10.1016/j.tetasy.2009.02.015.
Characterization of the biosynthesis, processing and kinetic mechanism of action of the enzyme deficient in mucopolysaccharidosis IIIC.
Fan X, Tkachyova I, Sinha A, Rigat B, Mahuran D
PLoS One. 2011; 6(9):e24951.
PMID: 21957468
PMC: 3177862.
DOI: 10.1371/journal.pone.0024951.
1-Deoxy-D-galactonojirimycins with dansyl capped N-substituents as β-galactosidase inhibitors and potential probes for GM1 gangliosidosis affected cell lines.
Frohlich R, Furneaux R, Mahuran D, Saf R, Stutz A, Tropak M
Carbohydr Res. 2011; 346(12):1592-8.
PMID: 21645885
PMC: 3158671.
DOI: 10.1016/j.carres.2011.05.010.
Crystal structure of β-hexosaminidase B in complex with pyrimethamine, a potential pharmacological chaperone.
Bateman K, Cherney M, Mahuran D, Tropak M, James M
J Med Chem. 2011; 54(5):1421-9.
PMID: 21265544
PMC: 3201983.
DOI: 10.1021/jm101443u.
Fluorous iminoalditols: a new family of glycosidase inhibitors and pharmacological chaperones.
Schitter G, Steiner A, Pototschnig G, Scheucher E, Thonhofer M, Tarling C
Chembiochem. 2010; 11(14):2026-33.
PMID: 20715263
PMC: 3198847.
DOI: 10.1002/cbic.201000192.
A sensitive fluorescence-based assay for monitoring GM2 ganglioside hydrolysis in live patient cells and their lysates.
Tropak M, Bukovac S, Rigat B, Yonekawa S, Wakarchuk W, Mahuran D
Glycobiology. 2009; 20(3):356-65.
PMID: 19917668
PMC: 2896968.
DOI: 10.1093/glycob/cwp183.
1-Deoxygalactonojirimycin-lysine hybrids as potent D-galactosidase inhibitors.
Steiner A, Schitter G, Stutz A, Wrodnigg T, Tarling C, Withers S
Bioorg Med Chem. 2008; 16(24):10216-20.
PMID: 18996021
PMC: 2910748.
DOI: 10.1016/j.bmc.2008.10.054.
Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis.
Maegawa G, Tropak M, Buttner J, Stockley T, Kok F, Clarke J
J Biol Chem. 2007; 282(12):9150-61.
PMID: 17237499
PMC: 1851921.
DOI: 10.1074/jbc.M609304200.
Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis.
Lemieux M, Mark B, Cherney M, Withers S, Mahuran D, James M
J Mol Biol. 2006; 359(4):913-29.
PMID: 16698036
PMC: 2910082.
DOI: 10.1016/j.jmb.2006.04.004.
Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.
Mark B, Mahuran D, Cherney M, Zhao D, Knapp S, James M
J Mol Biol. 2003; 327(5):1093-109.
PMID: 12662933
PMC: 2910754.
DOI: 10.1016/s0022-2836(03)00216-x.
A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside.
Sharma R, Bukovac S, Callahan J, Mahuran D
Biochim Biophys Acta. 2003; 1637(1):113-8.
PMID: 12527415
PMC: 2910081.
DOI: 10.1016/s0925-4439(02)00221-1.
Identification of the 6-sulfate binding site unique to alpha-subunit-containing isozymes of human beta-hexosaminidase.
Sharma R, Deng H, Leung A, Mahuran D
Biochemistry. 2001; 40(18):5440-6.
PMID: 11331008
PMC: 2910086.
DOI: 10.1021/bi0029200.
Characterization of the Glu and Asp residues in the active site of human beta-hexosaminidase B.
Hou Y, Vocadlo D, Leung A, Withers S, Mahuran D
Biochemistry. 2001; 40(7):2201-9.
PMID: 11329289
PMC: 2910085.
DOI: 10.1021/bi002018s.
Role of beta Arg211 in the active site of human beta-hexosaminidase B.
Hou Y, Vocadlo D, Withers S, Mahuran D
Biochemistry. 2000; 39(20):6219-27.
PMID: 10821697
PMC: 2910084.
DOI: 10.1021/bi992464j.
The Val192Leu mutation in the alpha-subunit of beta-hexosaminidase A is not associated with the B1-variant form of Tay-Sachs disease.
Hou Y, Vavougios G, Hinek A, Wu K, Hechtman P, Kaplan F
Am J Hum Genet. 1996; 59(1):52-8.
PMID: 8659543
PMC: 1915090.
